Skip to main content

Table 5 Staining for CLDN6 protein in EAC and GAC cohorts

From: The tight junction protein claudin 6 is a potential target for patient-individualized treatment in esophageal and gastric adenocarcinoma and is associated with poor prognosis

 

EAC (n = 808)

GAC (n = 589)

CLDN6 expression

n (%)

n (%)

0–Negative

736 (91.7)

571 (97.0)

1–Weak

48 (6.0)

12 (2.0)

2–Moderate

14 (1.7)

6 (1.0)

3–Strong

5 (0.6)

0 (0.0)

Positive (1–3)

67 (8.3)

18 (3.0)

1–9% of cells

4 (0.5)

9 (1.5)

10–19% of cells

16 (2.0)

3 (0.5)

 ≥ 20% of cells

47 (5.9)

6 (1.0)

 ≥ 50% of cells

24 (3.0)

1 (0.2)

  1. EAC esophageal adenocarcinoma, GAC gastric adenocarcinoma